Patients who are hepatitis B e antigen (HBeAg) positive with persistently elevated alanine aminotransferase (ALT) levels generally exhibit high HBV DNA concentrations, putting them at an increased risk of hepatocellular carcinoma and cirrhosis, necessitating antiviral therapy (2, –, 7). The gene discussed is GPT; the disease is hepatocellular carcinoma.